Search results
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 8 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
ImmunoGen (IMGN) Q1 Earnings and Sales Outpace Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 10 cents per share for first-quarter 2022, narrower than the...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
An Important History Lesson for Gene-Editing Investors
Motley Fool· 5 months agoThe history of biotechnology is full of examples of promising technologies that took decades to...
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoSpeakers on today's call will be Roger Dansey, interim chief executive officer and chief medical officer; Todd Simpson, chief financial officer; and Chip...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 6 days agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...
Why Gilead Sciences Stock Was a 5% Winner Today
Motley Fool· 2 years agoGilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company ...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
